Literature DB >> 21255765

Immunohistochemical expression of matrix metalloproteinases in squamous cell carcinoma of the tongue and lower lip.

Simone Souza Lobão Veras Barros1, Águida Cristina Gomes Henriques, Karuza Maria Alves Pereira, Ana Myriam Costa de Medeiros, Hébel Cavalcanti Galvão, Roseana de Almeida Freitas.   

Abstract

OBJECTIVE: To evaluate the immunohistochemical expression of MMP-1, -2, -7, -9 and -26 in oral squamous cell carcinomas (SCCs) according to tumour site and histological grade of malignancy. STUDY
DESIGN: Fifteen cases of SCC of the lower lip and 15 cases of tongue SCC were selected and divided into low grade malignancy (n = 17) and high grade malignancy (n = 13).
RESULTS: Higher immunohistochemical expression of MMPs by neoplastic cells was observed in tongue SCCs, with a statistically significant difference for MMP-9 (P < 0.05). High-grade SCCs showed a higher expression of MMPs, except for MMP-2, with a statistically significant difference for MMP-7 (P < 0.05) and MMP-26 (P < 0.05). In addition, a direct association was observed between morphological scores of malignancy and MMP immunoreactivity, with the association being significant for MMP-7 and MMP-26.
CONCLUSION: The present results demonstrate the important role of MMPs in the development of SCCs of the lower lip and tongue.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21255765     DOI: 10.1016/j.archoralbio.2010.11.022

Source DB:  PubMed          Journal:  Arch Oral Biol        ISSN: 0003-9969            Impact factor:   2.633


  7 in total

Review 1.  Matrix-metalloproteinases as targets for controlled delivery in cancer: An analysis of upregulation and expression.

Authors:  Kyle J Isaacson; M Martin Jensen; Nithya B Subrahmanyam; Hamidreza Ghandehari
Journal:  J Control Release       Date:  2017-01-31       Impact factor: 9.776

2.  Glycogen synthase kinase-3β mediated regulation of matrix metalloproteinase-9 and its involvement in oral squamous cell carcinoma progression and invasion.

Authors:  Kamdeo K Pramanik; Siddavaram Nagini; Abhay K Singh; Prajna Mishra; Tanushree Kashyap; Nidhi Nath; Manzar Alam; Ajay Rana; Rajakishore Mishra
Journal:  Cell Oncol (Dordr)       Date:  2017-11-13       Impact factor: 6.730

3.  Immunohistochemical expression of matrix metalloproteinase-1, matrix metalloproteinase-2 and matrix metalloproteinase-9, myofibroblasts and Ki-67 in actinic cheilitis and lip squamous cell carcinoma.

Authors:  Bianca C Bianco; Fernanda M Scotti; Daniella S C Vieira; Michelle T Biz; Renata G Castro; Filipe Modolo
Journal:  Int J Exp Pathol       Date:  2015-10-30       Impact factor: 1.925

4.  Expression of matrix metalloproteinases (MMPs-2, -7, -9, and -26) and tissue inhibitors of metalloproteinases (TIMPs-1 and -2) in pleomorphic adenomas and adenoid cystic carcinomas.

Authors:  Valéria Souza Freitas; Jean Nunes Dos Santos; Pedro Paulo de Andrade Santos; Cassiano Francisco Weege Nonaka; Leão Pereira Pinto; Lélia Batista de Souza
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-10-25       Impact factor: 2.503

5.  GM-CSF enhances tumor invasion by elevated MMP-2, -9, and -26 expression.

Authors:  Claudia M Gutschalk; Archana K Yanamandra; Nina Linde; Alice Meides; Sofia Depner; Margareta M Mueller
Journal:  Cancer Med       Date:  2012-11-26       Impact factor: 4.452

6.  Glutamate acid decarboxylase 1 promotes metastasis of human oral cancer by β-catenin translocation and MMP7 activation.

Authors:  Ryota Kimura; Atsushi Kasamatsu; Tomoyoshi Koyama; Chonji Fukumoto; Yukinao Kouzu; Morihiro Higo; Yosuke Endo-Sakamoto; Katsunori Ogawara; Masashi Shiiba; Hideki Tanzawa; Katsuhiro Uzawa
Journal:  BMC Cancer       Date:  2013-11-21       Impact factor: 4.430

7.  Expression of matrix metalloproteinase-7 correlates with the invasion of T1 colorectal carcinoma.

Authors:  Fumihiko Urushibara; Eisuke Shiozawa; Hideyuki Miyachi; Masashi Misawa; Tomonari Cho; Yusuke Takehara; Nana Arai; Toshitaka Funaki; Sakiko Tazawa; Mayumi Homma; Tomoko Norose; Mutsuko Omatsu; Toshiko Yamochi; Toshiaki Kunimura; Genshu Tate; Kazuho Honda; Ishida Fumio; Shin-Ei Kudo; Masafumi Takimoto
Journal:  Oncol Lett       Date:  2018-01-08       Impact factor: 2.967

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.